Jeffrey H. Burbank, Chief Executive Officer at NxStage Medical, Inc. (NXTM), sold 10,000 shares at $18.08 ($181K) on 2015-04-17, disclosed to the SEC on 2015-04-21.
Scheduled sale ($181k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NXTM | SELL | 2017-03-23 | $82K | — | Filing → |
| NXTM | SELL | 2017-03-22 | $83K | — | Filing → |
| NXTM | SELL | 2017-02-24 | $217K | — | Filing → |